(Q36620011)

English

Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type

scientific article published on December 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type (English)

1 reference

Europe PubMed Central

15 August 2017

ductal carcinoma

1 reference

based on heuristic

inferred from title

Marc van de Vijver

7

object named as

van de Vijver MJ

1 reference

Europe PubMed Central

15 August 2017

author name string

Vos CB

1

1 reference

Europe PubMed Central

15 August 2017

ter Haar NT

2

1 reference

Europe PubMed Central

15 August 2017

Rosenberg C

3

1 reference

Europe PubMed Central

15 August 2017

Peterse JL

4

1 reference

Europe PubMed Central

15 August 2017

Cleton-Jansen AM

5

1 reference

Europe PubMed Central

15 August 2017

Cornelisse CJ

6

1 reference

Europe PubMed Central

15 August 2017

language of work or name

0 references

publication date

1 December 1999

1 reference

Europe PubMed Central

15 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

15 August 2017

81

1 reference

Europe PubMed Central

15 August 2017

1410-1418

1 reference

Europe PubMed Central

15 August 2017

8

1 reference

Europe PubMed Central

15 August 2017

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6693372

0 references

Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362977

30 September 2017

Amplification units and translocation at chromosome 17q and c-erbB-2 overexpression in the pathogenesis of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362977

30 September 2017

Genetic changes in intraductal breast cancer detected by comparative genomic hybridization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362977

30 September 2017

Comparative genomic hybridisation of ductal carcinoma in situ of the breast: identification of regions of DNA amplification and deletion in common with invasive breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362977

30 September 2017

E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362977

30 September 2017

Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362977

30 September 2017

Allelic imbalance in the region of the BRCA1 gene in ductal carcinoma in situ of the breast

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362977

30 September 2017

E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362977

30 September 2017

Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362977

30 September 2017

Ductal carcinoma in situ: a proposal for a new classification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362977

30 September 2017

Somatic genetic changes in human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362977

30 September 2017

Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362977

30 September 2017

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362977

30 September 2017

Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362977

30 September 2017

Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362977

30 September 2017

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362977

30 September 2017

Genetic alterations during colorectal-tumor development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362977

30 September 2017

c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362977

30 September 2017

Amplification of a gene encoding a p53-associated protein in human sarcomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362977

30 September 2017

Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362977

30 September 2017

E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362977

28 June 2018

Relationship of a new histological categorization of ductal carcinoma in situ of the breast with size and the immunohistochemical expression of p53, c-erb B2, bcl-2, and ki-67.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362977

20 September 2018

Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362977

20 September 2018

Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362977

20 September 2018

BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362977

21 October 2018

Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/10604741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/10604741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/10604741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High frequency in vivo loss of heterozygosity is primarily a consequence of mitotic recombination

1 reference

https://pubmed.ncbi.nlm.nih.gov/10604741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias

1 reference

https://pubmed.ncbi.nlm.nih.gov/10604741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/10604741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10604741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53

1 reference

https://pubmed.ncbi.nlm.nih.gov/10604741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread

1 reference

https://pubmed.ncbi.nlm.nih.gov/10604741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10604741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The classification of ductal carcinoma in situ and its association with biological markers

1 reference

https://pubmed.ncbi.nlm.nih.gov/10604741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/10604741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

mdm2 gene alterations and mdm2 protein expression in breast carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/10604741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ductal carcinoma in situ of the breast: reproducibility of histological subtype analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6693372

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BJC.6693372

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36620011&oldid=1640819211"